FDA announced March 1 that it's expanding its country-wide import alert on enoki mushrooms to include China, subjecting them to detention without physical examination. The import alert was first issued in July 2022 and applied only to enoki mushrooms from South Korea.
FDA has issued its Enforcement Report for March 1, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.
On Feb. 24, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Feb. 23, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Feb. 22, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
FDA has issued its Enforcement Report for Feb. 22, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.
On Feb. 21, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
FDA recently issued a draft guidance document detailing its policies and recommendations for the labeling of plant-based milk alternatives. The draft guidance includes questions and answers on requirements for the name of plant-based milk alternatives and nutrient claims and statements on packaging. Comments on the draft guidance are due April 24, FDA said in a notice released Feb. 22.
On Feb. 17, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Feb. 16, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of: